# Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer

> clinical trial · VERIFIED · 2026-06-11

Status: RECRUITING · Sponsor: Beijing Biotech · Condition: Cholangiocarcinoma

- Company: Beijing Biotech
- Sector: cell therapy
- Primary source: https://clinicaltrials.gov/study/NCT07641036

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.